Painful Diabetic Neuropathy

More than 10% of the U.S. population has Diabetes.

 

All too often, those who receive a Diabetes diagnosis also suffer a painful complication from the condition known as Painful Diabetic Neuropathy, or PDN.  PDN causes numbness and pain in the limbs.  We are excited to offer a newly approved non-drug therapy proven to alleviate the burdensome pain. 

​

Where conventional therapies have failed, patients are finding relief from the Nevro HFX system, which is the only spinal cord stimulator with a specific FDA indication to treat PDN. 

​

The new system was shown to be safe and effective in the largest randomized clinical trial studying Spinal Cord Stimulation in patients with Painful Diabetic Neuropathy. 

​

​

Clinically Proven

Study participants demonstrated significantly improved and sustained outcomes with Spinal Cord Stimulation (SCS), including substantial, sustained pain relief and improved health-related quality of life.

 

The 6-month results for the randomized controlled trial (RCT) were previously published in JAMA Neurology  in April 2021, and the 12-month follow-up results and 6-month crossover patient data were recently presented at the American Diabetes Association 81st Scientific Sessions in June 2021.

​

• 85% of patients achieved at least 50% pain relief

​

• 76% average pain relief

​

• 92% of patients were satisfied with the treatment

​